Pozzi C.; Vanet A.; Francesconi V.; Tagliazucchi L.; Tassone G.; Venturelli A.; Spyrakis F.; Mazzorana M.; Costi M.P.; Tonelli M. Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 2023 10.1021/acs.jmedchem.2c01229 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149365125&doi=10.1021%2facs.jmedchem.2c01229&partnerID=40&md5=217937ae133929264232d74bc7a287f5
Tagliazucchi L.; Perea-Martinez A.; Fiorini G.; Manzano J.I.; Genovese F.; García-Hernández R.; Pinetti D.; Gamarro F.; Costi M.P. Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 2023 10.1021/acsinfecdis.2c00457 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149961889&doi=10.1021%2facsinfecdis.2c00457&partnerID=40&md5=b4472cf3570f9ad9099fe23f25d46b74
Linciano P.; Quotadamo A.; Luciani R.; Santucci M.; Zorn K.M.; Foil D.H.; Lane T.R.; Cordeiro da Silva A.; Santarem N.; B Moraes C.; Freitas-Junior L.; Wittig U.; Mueller W.; Tonelli M.; Ferrari S.; Venturelli A.; Gul S.; Kuzikov M.; Ellinger B.; Reinshagen J.; Ekins S.; Costi M.P. High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents 2023 10.1021/acs.jmedchem.3c01322 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178227560&doi=10.1021%2facs.jmedchem.3c01322&partnerID=40&md5=4784703d637e114edfc6c61827724107
Costi M.P.; Cordeiro-Da-Silva A. Call for Papers: One Health and Vector-Borne Parasitic Diseases 2023 10.1021/acsinfecdis.3c00304 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166759350&doi=10.1021%2facsinfecdis.3c00304&partnerID=40&md5=e47dcada00f041364448c6047472477e
D’Arca D.; Severi L.; Ferrari S.; Dozza L.; Marverti G.; Magni F.; Chinello C.; Pagani L.; Tagliazucchi L.; Villani M.; d’Addese G.; Piga I.; Conteduca V.; Rossi L.; Gurioli G.; De Giorgi U.; Losi L.; Costi M.P. Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 2023 10.3390/cancers15020412 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146742963&doi=10.3390%2fcancers15020412&partnerID=40&md5=f82038c438e270cae1276b964ff6822a